Skip to menu Skip to content Skip to footer
Professor Paul Robinson
Professor

Paul Robinson

Email: 

Overview

Background

Conjoint Professor Paul Robinson is the Deputy Director of the Children’s Health Environment Program within the Child Health Research Centre (CHRC), and Senior Staff Specialist in Respiratory and Sleep Medicine at the Queensland Children’s Hospital. His research program performs translational research outlining the role of peripheral airway function tests in early lung disease detection and ongoing monitoring of established disease.

He has led the development and standardisation of novel measures of lung function across the entire age range from infancy onwards, facilitating the development of commercial equipment available for widespread use. His research focuses on defining the clinical utility of two specific peripheral airway function tests (Multiple breath washout, MBW, and oscillometry) in important obstructive lung diseases (e.g., asthma, cystic fibrosis, and post bone marrow transplant pulmonary graft vs host disease) and in understanding the impacts of environmental exposures. Structure-function relationships have been explored using state-of-the-art imaging techniques, with the aim of also developing new strategies to reduce any radiation exposure associated with these to advance incorporation into clinical care (e.g., ultra-low dose CT).

These novel lung function tools not only in the hospital setting but also in the school and home setting, enabling the successful development of a parent-supervised remote monitoring strategy for asthma which has been shown to reflect clinically meaningful outcomes missed by conventional approaches. In collaboration with industry, this strategy is now being employed in a series of research projects.

Involvement in longitudinal birth cohorts has outlined the early lung function trajectories in health, and the identification of risk factors affecting normal lung development and contributing to the early development of asthma. Studies investigating environmental health have highlighted the adverse effects of ultrafine particle air pollution.

Professor Robinson’s standing as an international expert, both in terms of clinical and research experience, has led to broader leadership roles across national and international levels.

Availability

Professor Paul Robinson is:
Available for supervision

Research interests

  • Asthma

    Understanding mechanisms that underlie risks for developing asthma in susceptible children. Improving diagnosis of early asthma and monitoring of disease once established to prevent exacerbations and reduce risk of poor asthma outcomes.

  • Cystic Fibrosis

    Understanding the mechanisms underlying the development of lung disease early in life and why and how this progresses. Optimising the detection of early lung disease to facilitate earlier effective intervention to improve outcomes.

  • Pulmonary Graft vs. Host Disease

    Understanding the mechanisms underlying the development of respiratory complications following Haematopoietic Stem Cell Transplantation and why and how this progresses. Optimising the detection of early Pulmonary Graft-vs-Host disease to facilitate earlier intervention and improved outcomes.

  • Impact of environmental exposures in early life

    Improving methods of assessing environmental exposures and their effects across the lifespan and understanding how these increase long-tern risk of chronic disease in the lungs and other organ systems

Research impacts

Professor Robinson’s research program has informed a paradigm shift in management of chronic respiratory disease to ignore the reassurance of “normal” conventional lung function (spirometry) and target early lung disease detection arising in the peripheral airways and intervention through proactive (not reactive symptom-driven) strategies for 3 important obstructive lung conditions: (1) cystic fibrosis (CF); (2) asthma; and (3) post haemopoietic stem cell transplant (HSCT) pulmonary graft-vs-host disease (pGVHD).

Impact is evidenced by >150 published manuscripts of which >80 manuscripts are specific to this research program focus. A lead role on seminal consensus standards have resulted in a >4-times increase in MBW publications since their publication and widespread availability of robust commercial equipment (based on consensus recommendations adopted by all 4 global manufacturers). MBW has been formally as a primary outcome measure for CF intervention studies by independent institutions and integration into >30 international multicentre clinical trials. MBW has played a central role in registration of effective CFTR modulator therapy for young children, with significant projected survival benefits. Advances in oscillometry, including novel remote monitoring approaches targeting enhanced detection of disease exacerbation and prevention, have provided a platform for the first consensus clinical applications document for oscillometry.

Works

Search Professor Paul Robinson’s works on UQ eSpace

212 works between 2006 and 2025

141 - 160 of 212 works

2016

Journal Article

Clinical characteristics of adult asthma associated with small airway dysfunction

Kjellberg, S., Houltz, B. K., Zetterström, O., Robinson, P. D. and Gustafsson, Per M. (2016). Clinical characteristics of adult asthma associated with small airway dysfunction. Respiratory Medicine, 117, 92-102. doi: 10.1016/j.rmed.2016.05.028

Clinical characteristics of adult asthma associated with small airway dysfunction

2016

Journal Article

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

Gibson, P. G., Reddel, H., McDonald, V. M., Marks, G., Jenkins, C., Gillman, A., Upham, J., Sutherland, M., Rimmer, J., Thien, F., Katsoulotos, G. P., Cook, M., Yang, I., Katelaris, C., Bowler, S., Langton, D., Robinson, P., Wright, C., Yozghatlian, V., Burgess, S., Sivakumaran, P., Jaffe, A., Bowden, J., Wark, P. A., Yan, K. Y., Kritikos, V., Peters, M., Hew, M., Aminazad, A. ... Guo, M. (2016). Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry. Internal Medicine Journal, 46 (9), 1054-1062. doi: 10.1111/imj.13166

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

2016

Journal Article

A systematic approach to multiple breath nitrogen washout test quality

Jensen, Renee, Stanojevic, Sanja, Klingel, Michelle, Pizarro, Maria Ester, Hall, Graham L., Ramsey, Kathryn, Foong, Rachel, Saunders, Clare, Robinson, Paul D., Webster, Hailey, Hardaker, Kate, Kane, Mica and Ratjen, Felix (2016). A systematic approach to multiple breath nitrogen washout test quality. PLoS ONE, 11 (6) e0157523, 1-9. doi: 10.1371/journal.pone.0157523

A systematic approach to multiple breath nitrogen washout test quality

2016

Journal Article

Question 6: is there a role for Mannose-Binding Lectin measurement in Cystic Fibrosis management?

Prentice, Bernadette, McKay, Karen, Selvadurai, Hiran, Robinson, Paul D., Abel, Francois and Fitzgerald, Dominic A. (2016). Question 6: is there a role for Mannose-Binding Lectin measurement in Cystic Fibrosis management?. Paediatric Respiratory Reviews, 19, 46-48. doi: 10.1016/j.prrv.2015.09.008

Question 6: is there a role for Mannose-Binding Lectin measurement in Cystic Fibrosis management?

2016

Journal Article

Multiple breath washout: From renaissance to enlightenment?

Thamrin, Cindy, Hardaker, Kate and Robinson, Paul D. (2016). Multiple breath washout: From renaissance to enlightenment?. Pediatric Pulmonology, 51 (5), 447-449. doi: 10.1002/ppul.23316

Multiple breath washout: From renaissance to enlightenment?

2016

Conference Publication

Peripheral Airway Dysfunction In The Dunedin Cohort At Age 38 Years

Robinson, P. D., King, G. G., Sears, M. R., Hong, C. Yen and Hancox, R. (2016). Peripheral Airway Dysfunction In The Dunedin Cohort At Age 38 Years. International Conference of the American-Thoracic-Society (ATS), San Francisco Ca, May 13-18, 2016. NEW YORK: AMER THORACIC SOC.

Peripheral Airway Dysfunction In The Dunedin Cohort At Age 38 Years

2016

Conference Publication

Feature engineering and supervised learning classifiers for respiratory artefact removal in lung function tests

Pham, Thuy T., Nguyen, Diep N., Dutkiewicz, Eryk, McEwan, Alistair L., Thamrin, Cindy, Robinson, Paul D. and Leong, Philip H. W. (2016). Feature engineering and supervised learning classifiers for respiratory artefact removal in lung function tests. 59th Annual IEEE Global Communications Conference (IEEE GLOBECOM 2016), Washington, DC, United States, 4-8 December 2016. Piscataway, NJ, United States: Institute of Electrical and Electronics Engineers Inc.. doi: 10.1109/GLOCOM.2016.7841839

Feature engineering and supervised learning classifiers for respiratory artefact removal in lung function tests

2015

Journal Article

Poor standardisation of plethysmographic specific airways resistance measurement despite widespread use

Robinson, Paul D., Stocks, Janet, Marchal, Francois, Nielsen, Kim G., Thompson, Bruce R., Tomalak, Waldemar and Kirkby, Jane (2015). Poor standardisation of plethysmographic specific airways resistance measurement despite widespread use. European Respiratory Journal, 46 (6), 1811-1814. doi: 10.1183/13993003.00377-2015

Poor standardisation of plethysmographic specific airways resistance measurement despite widespread use

2015

Journal Article

Stratifying cystic fibrosis risk for newborn screen infants with equivocal sweat chloride levels

Groves, Tyler M., Robinson, Paul and Fitzgerald, Dominic A. (2015). Stratifying cystic fibrosis risk for newborn screen infants with equivocal sweat chloride levels. Pediatrics, 136 (5). doi: 10.1542/peds.2015-2786A

Stratifying cystic fibrosis risk for newborn screen infants with equivocal sweat chloride levels

2015

Conference Publication

Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations

Sonneveld, Nicole, Stanojevic, Sanja, Amin, Reshma, Aurora, Paul, Davies, Jane, Elborn, J. Stuart, Horsley, Alex, Latzin, Philipp, O'Neill, Katherine, Robinson, Paul, Scrase, Emma, Selvadurai, Hiran, Subbarao, Padmaja, Welsh, Liam, Yammine, Sophie and Ratjen, Felix (2015). Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations. European Respiratory Society. doi: 10.1183/09031936.00211914

Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations

2015

Journal Article

Ciclesonide-induced bronchospasm: an important but preventable side effect

Mandaliya, Payal H., Kennedy, Brendan, van Asperen, Peter and Robinson, Paul D. (2015). Ciclesonide-induced bronchospasm: an important but preventable side effect. Medical Journal of Australia, 203 (5), 233-233e.1. doi: 10.5694/mja15.00014

Ciclesonide-induced bronchospasm: an important but preventable side effect

2015

Conference Publication

Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk

Gonzalez, Miguel Garcia, McKay, Karen, Cooper, Peter, Selvadurai, Hiran, Fitzgerald, Dominic and Robinson, Paul D. (2015). Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2015.PA1300

Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk

2015

Conference Publication

Time between multiple breath nitrogen washout (MBNW) tests: Is duration of washout enough across childhood?

Hardaker, Kate, Jayasuriya, Geshani, Gustafsson, Per, Cooper, Peter, Fitzgerald, Dominic, Selvadurai, Hiran and Robinson, Paul (2015). Time between multiple breath nitrogen washout (MBNW) tests: Is duration of washout enough across childhood?. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2015.PA4147

Time between multiple breath nitrogen washout (MBNW) tests: Is duration of washout enough across childhood?

2015

Conference Publication

Lung clearance index (LCI) based on four different alveolar N-2 estimates in a large reference population aged 6-86 years

Strom, Maria, Houltz, Birgitta, Robinson, Paul D., Lindblad, Anders, Green, Kent, Nielsen, Kim G., Singer, Florian and Gustafsson, Per (2015). Lung clearance index (LCI) based on four different alveolar N-2 estimates in a large reference population aged 6-86 years. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2015.PA2286

Lung clearance index (LCI) based on four different alveolar N-2 estimates in a large reference population aged 6-86 years

2015

Conference Publication

FEV1/FVC ratio does not reflect peripheral airway ageing in an elderly reference population

Kjellberg, Sanna, Houltz, Birgitta, Robinson, Paul and Gustafsson, Per (2015). FEV1/FVC ratio does not reflect peripheral airway ageing in an elderly reference population. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2015.PA4616

FEV1/FVC ratio does not reflect peripheral airway ageing in an elderly reference population

2015

Conference Publication

Peripheral airway abnormalities are common in children post bone marrow transplantation

Jayasuriya, Geshani, King, Greg, Selvadurai, Hiran, Gabriel, Melissa, Gustaffson, Per, Hardaker, Kate, Kennedy, Brendan, Keogh, Steven, O'Brien, Ida, Shaw, Peter and Robinson, Paul (2015). Peripheral airway abnormalities are common in children post bone marrow transplantation. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2015.PA1269

Peripheral airway abnormalities are common in children post bone marrow transplantation

2015

Journal Article

Impact of lung function interpretation approach on pediatric bronchiolitis obliterans syndrome diagnosis after lung transplantation

Robinson, Paul D., Spencer, Helen and Aurora, Paul (2015). Impact of lung function interpretation approach on pediatric bronchiolitis obliterans syndrome diagnosis after lung transplantation. Journal of Heart and Lung Transplantation, 34 (8) 5991, 1082-1088. doi: 10.1016/j.healun.2015.03.010

Impact of lung function interpretation approach on pediatric bronchiolitis obliterans syndrome diagnosis after lung transplantation

2015

Journal Article

Long-term outcomes of children with intermediate sweat chloride values in infancy

Groves, Tyler, Robinson, Paul, Wiley, Veronica and Fitzgerald, Dominic A. (2015). Long-term outcomes of children with intermediate sweat chloride values in infancy. Journal of Pediatrics, 166 (6), 1469-1474.e3. doi: 10.1016/j.jpeds.2015.01.052

Long-term outcomes of children with intermediate sweat chloride values in infancy

2015

Journal Article

Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report

Subbarao, Padmaja, Milla, Carlos, Aurora, Paul, Davies, Jane C., Davis, Stephanie D., Hall, Graham L., Heltshe, Sonya, Latzin, Philipp, Lindblad, Anders, Pittman, Jessica E., Robinson, Paul D., Rosenfeld, Margaret, Singer, Florian, Starner, Tim D., Ratjen, Felix and Morgan, Wayne (2015). Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report. Annals of the American Thoracic Society, 12 (6), 932-939. doi: 10.1513/AnnalsATS.201501-021FR

Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report

2015

Journal Article

Ventilation inhomogeneities in children with congenital thoracic malformations

Mandaliya, Payal H., Morten, Matthew, Kumar, Rajendra, James, Alan, Deshpande, Aniruddh, Murphy, Vanessa E., Gibson, Peter G., Whitehead, Bruce, Robinson, Paul and Mattes, Joerg (2015). Ventilation inhomogeneities in children with congenital thoracic malformations. BMC Pulmonary Medicine, 15 (1) 25. doi: 10.1186/s12890-015-0023-1

Ventilation inhomogeneities in children with congenital thoracic malformations

Funding

Current funding

  • 2025 - 2026
    Think ZINC: Zinc immune-related Needs in Cystic fibrosis
    Cure4CF Foundation Research Grants
    Open grant
  • 2025
    Home-based monitoring with Oscillometry in paediatric Asthma: Improving our understanding of asthma control and behaviour during exacerbations
    Asthma Australia Incorporated
    Open grant
  • 2024 - 2025
    MBW LCI Overread Services in support of VX22-445-122
    Vertex Pharmaceuticals Inc
    Open grant
  • 2023 - 2028
    VX22-121-106
    Vertex Pharmaceuticals Inc
    Open grant
  • 2023 - 2026
    MBW Training and LCI Overread Services in Support of VX20-455-112
    Vertex Pharmaceuticals Inc
    Open grant
  • 2023 - 2026
    MBW Training and LCI Overread Services in Support of VX21-121-105
    Vertex Pharmaceuticals Inc
    Open grant
  • 2023 - 2027
    Translatable Evidence To Improve Lung Health Outcomes In First Nations People: A Cohort Study From Birth to 6 Years (NHRMC CTCS Grant administered by University of Melbourne)
    University of Melbourne
    Open grant
  • 2022 - 2025
    The GOAL Trial: Vascular Surgery (QACRF grant administered by Metro South Hospital)
    Metro South Hospital and Health Service
    Open grant

Past funding

  • 2023 - 2024
    ARCT-032-01: Phase 1/1b study of ARCT-032 in Healthy Adult Subjects and Adults with Cystic Fibrosis
    Arcturus Therapeutics Inc
    Open grant

Supervision

Availability

Professor Paul Robinson is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Remote monitoring of Paediatric Asthma to Improve Asthma Diagnosis and Control

    Childhood asthma mortality remains substantial, and rates of hospitalisation are increasing globally in young children. This is driven by poor asthma control (which affects 50% of asthmatics) and ongoing exacerbations (which affects 25%). Of the 40,000 admissions each year, 80% are preventable! Current symptom-based management approaches fail – limited by poor perception/reporting by children and parents - and conventional spirometry/peak flow is insensitive or too challenging for this setting. In addition, the preschool age range is a critical period in asthma pathogenesis: symptoms emerge, airway structure changes, and a window for intervention exists before permanent lung function deficit is established by early school age. Preschool symptom-based diagnostic and/or predictive tools (for later asthma) perform poorly and ignore lung function due to spirometry’s limitations. Improved ability to differentiate early asthma phenotypes is a priority of international societies.

    This research program consists of a series of projects to analyse existing, and collect new, data to define the clinical utility of a unique remote home-based monitoring strategy focused on the day-to-day variability of a novel and sensitive lung function test. Studies will investigate its ability to correctly identify evolving asthma, detect loss of asthma control and provide an early signal of an impending asthma exacerbation to improve long term asthma outcomes.

  • Improving detection of Pulmonary Graft-vs-Host Disease to facilitate earlier intervention

    Chronic Graft-vs-Host Disease affects 60% of Haematopoeitic Stem Cell Transplant (HSCT) survivors by 6 years after their transplant, affecting multiple organs including skin, liver, gastrointestinal tract and lungs. Gold standard for pulmonary GVHD diagnosis is abnormal spirometry and subsequent CT-based imaging. Pulmonary GVHD is estimated to affect 20% of all subjects post HSCT yet this incidence is a gross underestimate due to the insensitivity of spirometry to detect peripheral lung changes. This leads to late diagnosis, poor response to treatment, and poor prognosis (5-year mortality is 85%). Better tools to detect and monitor pulmonary GVHD are urgently required.

    This research program builds on previous work highlighting the potential utility of novel peripheral airway function test in this setting. It will analyse both local data and pooled international data across 12 international centres (including both paediatric and adult data) to define the utility of these tools to provide an earlier diagnosis of pulmonary GVHD to facilitate earlier invention and improve outcomes. It will also explore novel applications of these tests to enhance detection further in the initial period post HSCT to predict and detect those at risk.

  • Remote monitoring of Paediatric Asthma to Improve Asthma Diagnosis and Control

    Childhood asthma mortality remains substantial, and rates of hospitalisation are increasing globally in young children. This is driven by poor asthma control (which affects 50% of asthmatics) and ongoing exacerbations (which affects 25%). Of the 40,000 admissions each year, 80% are preventable! Current symptom-based management approaches fail – limited by poor perception/reporting by children and parents - and conventional spirometry/peak flow is insensitive or too challenging for this setting. In addition, the preschool age range is a critical period in asthma pathogenesis: symptoms emerge, airway structure changes, and a window for intervention exists before permanent lung function deficit is established by early school age. Preschool symptom-based diagnostic and/or predictive tools (for later asthma) perform poorly and ignore lung function due to spirometry’s limitations. Improved ability to differentiate early asthma phenotypes is a priority of international societies. This research program consists of a series of projects to analyse existing, and collect new, data to define the clinical utility of a unique remote home-based monitoring strategy focused on the day-to-day variability of a novel and sensitive lung function test. Studies will investigate its ability to correctly identify evolving asthma, detect loss of asthma control and provide an early signal of an impending asthma exacerbation to improve long term asthma outcomes.

    This program of research includes projects suitable for PhD, honours or masters students.

    For more information, contact Professor Paul Robinson at paul.robinson@uq.edu.au.

  • Assessing the impact of a Complex Asthma model of care to service all eligible Queensland children

    A significant driver of the huge healthcare burden of asthma is children with difficult-to-treat or severe asthma (5-10% of childhood asthma, termed collectively as “Complex Asthma”). A recent survey of Australian and New Zealand paediatric tertiary services has highlighted the lack of a standardised approach to services and issues adequately identifying these children affected to ensure access to recommended models of care. At Queensland Children’s hospital (QCH) we have established a unique multidisciplinary team (MDT) service, involving nine different medical teams: Respiratory, Allergy & Immunology, Psychology, Psychiatry, Adolescent Medicine, Speech Pathology, Physiotherapy, ENT and Social work. The research program will focus on evaluating the effectiveness of this approach through i) the creation of a complex asthma database to assess health outcomes, describe key factors predicting those outcomes and enable a cost-effectiveness analysis, ii) the evaluation of currently employed screening questionnaires to correctly identify important co-morbidities, and iii) using the established Project ECHO platform at QCH, the creation of a community of practice and an education module to educate and empower non-tertiary community-based services to better identify and contribute to ongoing management the impact of which will be formally assessed. This work coincides with the establishment of a national Australian and New Zealand Paediatric Severe Asthma Registry (led by QCH staff) which will enable benchmarking of outcomes to data collected at other tertiary centres.

    This program of research includes projects suitable for PhD, honours or masters students

    For more information, contact Professor Paul Robinson at paul.robinson@uq.edu.au

  • Improving detection of Pulmonary Graft-vs-Host Disease to facilitate earlier intervention

    Chronic Graft-vs-Host Disease affects 60% of Haematopoietic Stem Cell Transplant (HSCT) survivors by 6 years after their transplant, affecting multiple organs including skin, liver, gastrointestinal tract and lungs. Gold standard for pulmonary GVHD diagnosis is abnormal spirometry and subsequent CT-based imaging. Pulmonary GVHD is estimated to affect 20% of all subjects post HSCT yet this incidence is a gross underestimate due to the insensitivity of spirometry to detect peripheral lung changes. This leads to late diagnosis, poor response to treatment, and poor prognosis (5-year mortality is 85%). Better tools to detect and monitor pulmonary GVHD are urgently required.

    This research program builds on previous work highlighting the potential utility of novel peripheral airway function test in this setting. It will analyse both local data and pooled international data across 12 international centres (including both paediatric and adult data) to define the utility of these tools to provide an earlier diagnosis of pulmonary GVHD to facilitate earlier invention and improve outcomes. It will also explore novel applications of these tests in a new prospective cohort to enhance detection further in the initial period post HSCT to predict and detect those at risk.

    This program of research includes projects suitable for PhD, honours or masters students.

    For more information, contact Professor Paul Robinson at paul.robinson@uq.edu.au.

  • Defining early lung function and respiratory health trajectories in First Nations infants

    Disparities in health for indigenous communities are a global issue. The Strong Families Study is a First Nations peoples co-designed cohort to support improved perinatal and early childhood outcomes. It is the largest birth cohort study of its kind to date and the first inclusive of mothers, partners, and their children. This research program will focus on identifying important events happening within the first year of life that determine respiratory health and lung function trajectories in recruited infants. The projects will focus on pre-natal and post-natal factors determining i) baseline offspring lung function at 6 weeks, ii) lung function trajectories determined by respiratory function tested at 6 weeks and 12 months and iii) respiratory health defined by episodes of wheeze and bronchiolitis within the first 12 months of life. Relationships observed within this cohort will be compared to those within other important birth cohorts both nationally (Barwon Infant Study) and internationally (Drakenstein study, South Africa).

    This program of research includes projects suitable for PhD, honours or masters students. Experience working with first nations communities, with children and in lung function techniques is desirable.

    For more information, contact Professor Paul Robinson at paul.robinson@uq.edu.au.

Media

Enquiries

For media enquiries about Professor Paul Robinson's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au